X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (121) 121
Patent (69) 69
Publication (9) 9
Dissertation (5) 5
Book Chapter (4) 4
Conference Proceeding (2) 2
Newspaper Article (2) 2
Book Review (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
human necessities (61) 61
hygiene (61) 61
medical or veterinary science (61) 61
preparations for medical, dental, or toilet purposes (61) 61
index medicus (53) 53
specific therapeutic activity of chemical compounds ormedicinal preparations (53) 53
humans (38) 38
hepacivirus - genetics (19) 19
analysis (18) 18
pharmacology & pharmacy (18) 18
hepacivirus - drug effects (17) 17
genotype (16) 16
microbiology (16) 16
antiviral agents (15) 15
chemistry (14) 14
female (14) 14
hepatitis c (14) 14
heterocyclic compounds (14) 14
in-vitro (14) 14
metallurgy (14) 14
organic chemistry (14) 14
hcv (13) 13
hepatitis c virus (13) 13
ribavirin (12) 12
virus diseases (12) 12
antiviral agents - pharmacology (11) 11
genetic aspects (11) 11
viruses (11) 11
digestive system diseases (10) 10
patients (10) 10
viral nonstructural proteins - genetics (10) 10
antiviral agents - therapeutic use (9) 9
biochemical phenomena, metabolism, and nutrition (9) 9
cirrhosis (9) 9
gastroenterology & hepatology (9) 9
interferon (9) 9
sofosbuvir (9) 9
biochemistry & molecular biology (8) 8
breast cancer (8) 8
glecaprevir (8) 8
hepatitis (8) 8
male (8) 8
medical research (8) 8
pibrentasvir (8) 8
resistance (8) 8
adult (7) 7
drug resistance, viral - genetics (7) 7
health aspects (7) 7
hepatitis c, chronic - drug therapy (7) 7
meteorology & atmospheric sciences (7) 7
middle aged (7) 7
monsoons (7) 7
mutation (7) 7
ns5a (7) 7
phosphorylation (7) 7
research (7) 7
viral nonstructural proteins - antagonists & inhibitors (7) 7
virology (7) 7
animals (6) 6
antioxidant activity (6) 6
antioxidants (6) 6
cells (6) 6
chronic infection (6) 6
daclatasvir (6) 6
drug therapy, combination (6) 6
earth sciences (6) 6
genotypes (6) 6
hepatitis c, chronic - virology (6) 6
india (6) 6
medicine, experimental (6) 6
open-label (6) 6
temperature (6) 6
aged (5) 5
agriculture (5) 5
anilides - therapeutic use (5) 5
animal husbandry (5) 5
antiviral agents - pharmacokinetics (5) 5
benzimidazoles - therapeutic use (5) 5
biocides, e.g. as disinfectants, as pesticides, as herbicides (5) 5
biological response modifiers (5) 5
breast neoplasms - genetics (5) 5
carbamates - therapeutic use (5) 5
cell line (5) 5
climate change (5) 5
climatology (5) 5
counting (5) 5
direct-acting antivirals (5) 5
epidemiology (5) 5
fishing (5) 5
food science & technology (5) 5
forestry (5) 5
genomes (5) 5
hepatitis c - drug therapy (5) 5
hunting (5) 5
infections (5) 5
inhibitor (5) 5
pest repellants or attractants (5) 5
physics (5) 5
plant growth regulators (5) 5
precipitation (5) 5
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (193) 193
French (20) 20
Chinese (7) 7
German (7) 7
Spanish (5) 5
Portuguese (4) 4
Japanese (1) 1
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Gastroenterology, ISSN 0944-1174, 4/2018, Volume 53, Issue 4, pp. 566 - 575
Once-daily, orally administered, co-formulated glecaprevir (NS3/4A protease inhibitor) and pibrentasvir (NS5A inhibitor) (G/P) demonstrated pangenotypic... 
Pibrentasvir | Cirrhosis | Medicine & Public Health | Glecaprevir | Colorectal Surgery | Hepatology | Gastroenterology | Renal failure | Abdominal Surgery | Special population | Surgical Oncology | PLUS RIBAVIRIN | SOFOSBUVIR | CHRONIC HEPATITIS-C | OPEN-LABEL | TREATMENT-NAIVE | PHASE-3 TRIAL | DACLATASVIR | GASTROENTEROLOGY & HEPATOLOGY | BURDEN | EPIDEMIOLOGY | Quinoxalines - adverse effects | Humans | Middle Aged | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Male | RNA, Viral - blood | Hepatitis C, Chronic - complications | Young Adult | Treatment Failure | Adult | Female | Renal Insufficiency - complications | Benzimidazoles - adverse effects | Drug Therapy, Combination | Benzimidazoles - therapeutic use | Quinoxalines - therapeutic use | Hepacivirus - isolation & purification | Antiviral Agents - therapeutic use | Genotype | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Sulfonamides - therapeutic use | Antiviral Agents - adverse effects | Adolescent | Sulfonamides - adverse effects | Aged | Sustained Virologic Response | Medical research | Protease inhibitors | Proteases | Analysis | Medicine, Experimental | Genetic aspects | Biological response modifiers | Hepatitis C virus | Health aspects | Liver cirrhosis | Kidneys | Hemodialysis | Oral administration | Chronic infection | Interferon | Ribonucleic acid--RNA | Patients | Glomerular filtration rate | Kidney transplantation | Index Medicus | Original —Liver, Pancreas, and Biliary Tract
Journal Article
Current Sociology, ISSN 0011-3921, 7/2016, Volume 64, Issue 4, pp. 603 - 619
Violence against women takes diverse forms across the world. Domestic violence in South Asia has received special attention because of both its prevalence and... 
Supreme Court rulings | Domestic violence | laws | family | India
Journal Article
The Lancet Infectious Diseases, ISSN 1473-3099, 10/2017, Volume 17, Issue 10, pp. 1062 - 1068
Journal Article
Climate Dynamics, ISSN 0930-7575, 4/2017, Volume 48, Issue 7, pp. 2489 - 2505
Journal Article
Journal of Gastroenterology, ISSN 0944-1174, 4/2018, Volume 53, Issue 4, pp. 557 - 565
The once-daily, all oral, RBV-free, pangenotypic direct-acting anti-viral regimen consisting of co-formulated NS3/4A protease inhibitor glecaprevir and NS5A... 
Medicine & Public Health | Colorectal Surgery | Hepatology | Gastroenterology | Abdominal Surgery | Glecaprevir/pibrentasvir | Hepatitis C virus | Surgical Oncology | Direct-acting antivirals | ASIA | PHASE-3 TRIAL | RIBAVIRIN | COMPENSATED CIRRHOSIS | COMBINATION | GASTROENTEROLOGY & HEPATOLOGY | BURDEN | EPIDEMIOLOGY | Quinoxalines - adverse effects | Anilides - therapeutic use | Age Distribution | Humans | Middle Aged | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Male | RNA, Viral - blood | Hepatitis C, Chronic - complications | Quinoxalines - blood | Sulfonamides - blood | Aged, 80 and over | Ritonavir - therapeutic use | Adult | Female | Benzimidazoles - adverse effects | Drug Therapy, Combination | Benzimidazoles - blood | Benzimidazoles - therapeutic use | Quinoxalines - therapeutic use | Hepacivirus - isolation & purification | Liver Cirrhosis - drug therapy | Drug Administration Schedule | Antiviral Agents - blood | Antiviral Agents - therapeutic use | Viral Nonstructural Proteins - genetics | Liver Cirrhosis - blood | Hepatitis C, Chronic - drug therapy | Hepatitis C, Chronic - blood | Macrocyclic Compounds - therapeutic use | Liver Cirrhosis - virology | Sulfonamides - therapeutic use | Antiviral Agents - adverse effects | Sulfonamides - adverse effects | Aged | Sustained Virologic Response | Carbamates - therapeutic use | Drug Combinations | Virus diseases | Medical research | Protease inhibitors | Proteases | Medicine, Experimental | Genetic aspects | Health aspects | Liver cirrhosis | Cirrhosis | Antiviral agents | Ritonavir | Chronic infection | Proteinase inhibitors | Hepatitis C | Patients | Genotypes | Index Medicus | Glecaprevir | pibrentasvir | Original —Liver, Pancreas, and Biliary Tract
Journal Article
Research Journal of Pharmacy and Technology, ISSN 0974-3618, 11/2016, Volume 9, Issue 11, pp. 1843 - 1845
Journal Article
Journal Article
Hepatology, ISSN 0270-9139, 02/2018, Volume 67, Issue 2, pp. 514 - 523
This study assessed the efficacy and safety of ribavirin‐free coformulated glecaprevir/pibrentasvir (G/P) in patients with hepatitis C virus genotype 3... 
NATURAL PREVALENCE | FIBROSIS | VELPATASVIR | STEATOSIS | SOFOSBUVIR | RESISTANCE | HCV GENOTYPE | INFECTION | DACLATASVIR | GASTROENTEROLOGY & HEPATOLOGY | PROGRESSION | Cirrhosis | Hepatitis | Clinical trials | Interferon | Hepatitis C | Patients | Ribavirin | Genotypes | Original
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2014, Volume 134, Issue 5, pp. 1153 - 1162
Journal Article
9/2015, ISBN 1785602632, Volume 9, 28
Abstract Purpose The practices and arrangements within a family can create grounds for violence. Although we agree that family processes are important, we... 
Sociology | Sociology of the family | Domestic violence | Family | Gender | Court judgments | India
Book Chapter
Current Pharmacogenomics and Personalized Medicine, ISSN 1875-6921, 06/2016, Volume 14, Issue 1, pp. 56 - 64
Background: The drug response varies from person to person. The possibility for the drugs to move to a large number of bio molecular targets and lack of... 
BRCA-1 | Personalized drugs | Soft drug | Chemical drug delivery systems | Effective drug response | Retro-metabolic design
Journal Article